Bausch Health Net Worth
Bausch Health Net Worth Breakdown | BHC |
Bausch Health Net Worth Analysis
Bausch Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Bausch Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Bausch Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Bausch Health's net worth analysis. One common approach is to calculate Bausch Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Bausch Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Bausch Health's net worth. This approach calculates the present value of Bausch Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Bausch Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Bausch Health's net worth. This involves comparing Bausch Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Bausch Health's net worth relative to its peers.
Enterprise Value |
|
To determine if Bausch Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Bausch Health's net worth research are outlined below:
| Bausch Health generated a negative expected return over the last 90 days | |
| Bausch Health has high historical volatility and very poor performance | |
| The company reported the last year's revenue of 8.76 B. Reported Net Loss for the year was (611 M) with profit before taxes, overhead, and interest of 6.71 B. | |
| Bausch Health has a strong financial position based on the latest SEC filings | |
| About 73.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: Bausch Health Companies Inc Announces XIFAXANs Selection for Medicare Negotiation Program |
Bausch Health Quarterly Good Will |
|
Bausch Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Bausch Health Companies. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Bausch Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Bausch Health Target Price Consensus
Bausch target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Bausch Health's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 6 | Buy |
Most Bausch analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Bausch stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Bausch Health Companies, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationBausch Health Target Price Projection
Bausch Health's current and average target prices are 7.44 and 9.50, respectively. The current price of Bausch Health is the price at which Bausch Health Companies is currently trading. On the other hand, Bausch Health's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Bausch Health Market Quote on 18th of January 2025
Target Price
Analyst Consensus On Bausch Health Target Price
Know Bausch Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Bausch Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bausch Health Companies backward and forwards among themselves. Bausch Health's institutional investor refers to the entity that pools money to purchase Bausch Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Franklin Resources Inc | 2024-09-30 | 5.3 M | Kohlberg Kravis Roberts & Co Lp | 2024-09-30 | 5.2 M | Citadel Advisors Llc | 2024-09-30 | 5.1 M | Bank Of Montreal | 2024-09-30 | 3.8 M | Bmo Capital Markets Corp. | 2024-09-30 | 3.8 M | Norges Bank | 2024-06-30 | 3.8 M | Goldman Sachs Group Inc | 2024-09-30 | 3.4 M | Arrowstreet Capital Limited Partnership | 2024-09-30 | 3.3 M | Laurion Capital Management Lp | 2024-09-30 | 3.1 M | Icahn Carl C | 2024-09-30 | 34.7 M | Goldentree Asset Management Lp | 2024-09-30 | 29.4 M |
Follow Bausch Health's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 2.83 B.Market Cap |
|
Project Bausch Health's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.07) | (0.07) | |
| Return On Capital Employed | 0.05 | 0.05 | |
| Return On Assets | (0.02) | (0.02) | |
| Return On Equity | 0.52 | 0.55 |
When accessing Bausch Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Bausch Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Bausch Health's profitability and make more informed investment decisions.
Please note, the presentation of Bausch Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bausch Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Bausch Health's management manipulating its earnings.
Evaluate Bausch Health's management efficiency
Bausch Health Companies has Return on Asset of 0.0415 % which means that on every $100 spent on assets, it made $0.0415 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (23.0454) %, meaning that it generated no profit with money invested by stockholders. Bausch Health's management efficiency ratios could be used to measure how well Bausch Health manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 0.55, whereas Return On Tangible Assets are projected to grow to (0.07). At present, Bausch Health's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 6.8 B, whereas Non Current Assets Total are forecasted to decline to about 12.7 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.20) | (0.19) | |
| Tangible Book Value Per Share | (55.77) | (52.98) | |
| Enterprise Value Over EBITDA | 12.50 | 11.87 | |
| Price Book Value Ratio | (3.30) | (3.13) | |
| Enterprise Value Multiple | 12.50 | 11.87 | |
| Price Fair Value | (3.30) | (3.13) | |
| Enterprise Value | 21.9 B | 17.7 B |
Examining the leadership quality of Bausch Health Companies offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Enterprise Value Revenue 2.4926 | Revenue | Quarterly Revenue Growth 0.122 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bausch Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bausch Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Bausch Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Bausch Health Corporate Filings
F4 | 2nd of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 1st of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 31st of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
| 20th of September 2024 Other Reports | ViewVerify |
Bausch Health Earnings Estimation Breakdown
The calculation of Bausch Health's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Bausch Health is estimated to be 0.938 with the future projection ranging from a low of 0.8875 to a high of 0.9975. Please be aware that this consensus of annual earnings estimates for Bausch Health Companies is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.89 Lowest | Expected EPS | 1.00 Highest |
Bausch Health Earnings Projection Consensus
Suppose the current estimates of Bausch Health's value are higher than the current market price of the Bausch Health stock. In this case, investors may conclude that Bausch Health is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Bausch Health's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2024 | Current EPS (TTM) | |
| 6 | 79.83% | 1.13 | 0.938 | -0.47 |
Bausch Health Earnings History
Earnings estimate consensus by Bausch Health Companies analysts from Wall Street is used by the market to judge Bausch Health's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Bausch Health's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Bausch Health Quarterly Gross Profit |
|
Bausch Health Earnings per Share Projection vs Actual
Actual Earning per Share of Bausch Health refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Bausch Health Companies predict the company's earnings will be in the future. The higher the earnings per share of Bausch Health, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Bausch Health Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Bausch Health, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Bausch Health should always be considered in relation to other companies to make a more educated investment decision.Bausch Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Bausch Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-10-30 | 2024-09-30 | 1.02 | 1.13 | 0.11 | 10 | ||
2024-08-01 | 2024-06-30 | 0.88 | 0.027 | -0.853 | 96 | ||
2024-05-02 | 2024-03-31 | 0.72 | 0.6 | -0.12 | 16 | ||
2024-02-22 | 2023-12-31 | 1.02 | 1.15 | 0.13 | 12 | ||
2023-11-02 | 2023-09-30 | 0.92 | 1.02 | 0.1 | 10 | ||
2023-08-03 | 2023-06-30 | 0.78 | 0.82 | 0.04 | 5 | ||
2023-05-04 | 2023-03-31 | 0.72 | 0.52 | -0.2 | 27 | ||
2023-02-23 | 2022-12-31 | 0.91 | 1.03 | 0.12 | 13 | ||
2022-11-03 | 2022-09-30 | 0.84 | 0.76 | -0.08 | 9 | ||
2022-08-09 | 2022-06-30 | 0.89 | 0.56 | -0.33 | 37 | ||
2022-05-10 | 2022-03-31 | 1.03 | 0.73 | -0.3 | 29 | ||
2022-02-23 | 2021-12-31 | 1.12 | 1.28 | 0.16 | 14 | ||
2021-11-02 | 2021-09-30 | 1.04 | 1.16 | 0.12 | 11 | ||
2021-08-03 | 2021-06-30 | 0.95 | 0.97 | 0.02 | 2 | ||
2021-05-04 | 2021-03-31 | 0.94 | 1.04 | 0.1 | 10 | ||
2021-02-24 | 2020-12-31 | 1.12 | 1.33 | 0.21 | 18 | ||
2020-11-03 | 2020-09-30 | 1.04 | 1.32 | 0.28 | 26 | ||
2020-08-06 | 2020-06-30 | 0.66 | 0.46 | -0.2 | 30 | ||
2020-05-07 | 2020-03-31 | 0.88 | 0.88 | 0.0 | 0 | ||
2020-02-19 | 2019-12-31 | 1.15 | 1.12 | -0.03 | 2 | ||
2019-11-04 | 2019-09-30 | 1.09 | 1.19 | 0.1 | 9 | ||
2019-08-06 | 2019-06-30 | 1.04 | 1.04 | 0.0 | 0 | ||
2019-05-06 | 2019-03-31 | 0.86 | 1.02 | 0.16 | 18 | ||
2019-02-20 | 2018-12-31 | 0.84 | 1.03 | 0.19 | 22 | ||
2018-11-06 | 2018-09-30 | 0.84 | 1.13 | 0.29 | 34 | ||
2018-08-07 | 2018-06-30 | 0.8 | 0.93 | 0.13 | 16 | ||
2018-05-08 | 2018-03-31 | 0.6 | 0.88 | 0.28 | 46 | ||
2018-02-28 | 2017-12-31 | 0.97 | 0.98 | 0.01 | 1 | ||
2017-11-07 | 2017-09-30 | 0.89 | 1.04 | 0.15 | 16 | ||
2017-08-08 | 2017-06-30 | 0.94 | 1.03 | 0.09 | 9 | ||
2017-05-09 | 2017-03-31 | 0.87 | 0.78 | -0.09 | 10 | ||
2017-02-28 | 2016-12-31 | 1.2 | 1.26 | 0.06 | 5 | ||
2016-11-08 | 2016-09-30 | 1.75 | 1.55 | -0.2 | 11 | ||
2016-08-09 | 2016-06-30 | 1.47 | 1.4 | -0.07 | 4 | ||
2016-06-07 | 2016-03-31 | 1.37 | 1.27 | -0.1 | 7 | ||
2016-03-15 | 2015-12-31 | 2.61 | 2.5 | -0.11 | 4 | ||
2015-10-19 | 2015-09-30 | 2.7 | 2.74 | 0.04 | 1 | ||
2015-07-23 | 2015-06-30 | 2.46 | 2.56 | 0.1 | 4 | ||
2015-04-29 | 2015-03-31 | 2.34 | 2.36 | 0.02 | 0 | ||
2015-02-22 | 2014-12-31 | 2.55 | 2.58 | 0.03 | 1 | ||
2014-10-20 | 2014-09-30 | 1.99 | 2.11 | 0.12 | 6 | ||
2014-07-31 | 2014-06-30 | 1.9 | 1.91 | 0.01 | 0 | ||
2014-05-08 | 2014-03-31 | 1.72 | 1.76 | 0.04 | 2 | ||
2014-02-27 | 2013-12-31 | 2.06 | 2.15 | 0.09 | 4 | ||
2013-10-31 | 2013-09-30 | 1.41 | 1.43 | 0.02 | 1 | ||
2013-08-07 | 2013-06-30 | 1.28 | 1.34 | 0.06 | 4 | ||
2013-05-02 | 2013-03-31 | 1.25 | 1.3 | 0.05 | 4 | ||
2013-02-28 | 2012-12-31 | 1.2 | 1.22 | 0.02 | 1 | ||
2012-11-02 | 2012-09-30 | 1.12 | 1.15 | 0.03 | 2 | ||
2012-08-02 | 2012-06-30 | 0.99 | 1.01 | 0.02 | 2 | ||
2012-05-03 | 2012-03-31 | 0.96 | 0.99 | 0.03 | 3 | ||
2012-02-27 | 2011-12-31 | 0.85 | 0.94 | 0.09 | 10 | ||
2011-11-03 | 2011-09-30 | 0.57 | 0.66 | 0.09 | 15 | ||
2011-08-04 | 2011-06-30 | 0.66 | 0.73 | 0.07 | 10 | ||
2011-05-09 | 2011-03-31 | 0.51 | 0.62 | 0.11 | 21 | ||
2011-02-24 | 2010-12-31 | 0.45 | 0.51 | 0.06 | 13 | ||
2010-11-04 | 2010-09-30 | 0.48 | 0.44 | -0.04 | 8 | ||
2010-08-05 | 2010-06-30 | 0.26 | 0.6 | 0.34 | 130 | ||
2010-05-06 | 2010-03-31 | 0.27 | 0.59 | 0.32 | 118 | ||
2010-02-25 | 2009-12-31 | 0.37 | 0.56 | 0.19 | 51 | ||
2009-11-05 | 2009-09-30 | 0.4 | 0.32 | -0.08 | 20 | ||
2009-08-06 | 2009-06-30 | 0.34 | 0.34 | 0.0 | 0 | ||
2009-05-06 | 2009-03-31 | 0.3 | 0.28 | -0.02 | 6 | ||
2009-02-26 | 2008-12-31 | 0.32 | 0.34 | 0.02 | 6 | ||
2008-11-06 | 2008-09-30 | 0.29 | 0.36 | 0.07 | 24 | ||
2008-08-13 | 2008-06-30 | 0.34 | 0.37 | 0.03 | 8 | ||
2008-05-08 | 2008-03-31 | 0.39 | 0.38 | -0.01 | 2 | ||
2008-03-13 | 2007-12-31 | 0.39 | 0.45 | 0.06 | 15 | ||
2007-11-08 | 2007-09-30 | 0.4 | 0.42 | 0.02 | 5 | ||
2007-08-08 | 2007-06-30 | 0.37 | 0.4 | 0.03 | 8 | ||
2007-05-10 | 2007-03-31 | 0.38 | 0.58 | 0.2 | 52 | ||
2007-03-15 | 2006-12-31 | 0.77 | 0.93 | 0.16 | 20 | ||
2006-11-09 | 2006-09-30 | 0.65 | 0.83 | 0.18 | 27 | ||
2006-08-10 | 2006-06-30 | 0.46 | 0.5 | 0.04 | 8 | ||
2006-05-11 | 2006-03-31 | 0.37 | 0.43 | 0.06 | 16 | ||
2006-03-23 | 2005-12-31 | 0.74 | 0.77 | 0.03 | 4 | ||
2005-11-11 | 2005-09-30 | 0.6 | 0.69 | 0.09 | 15 | ||
2005-08-04 | 2005-06-30 | 0.26 | 0.34 | 0.08 | 30 | ||
2005-05-05 | 2005-03-31 | 0.07 | 0.07 | 0.0 | 0 | ||
2005-03-10 | 2004-12-31 | 0.5 | 0.58 | 0.08 | 16 | ||
2004-11-04 | 2004-09-30 | 0.37 | 0.31 | -0.06 | 16 | ||
2004-08-04 | 2004-06-30 | 0.24 | 0.28 | 0.04 | 16 | ||
2004-04-29 | 2004-03-31 | 0.13 | 0.18 | 0.05 | 38 | ||
2004-03-03 | 2003-12-31 | 0.28 | 0.28 | 0.0 | 0 | ||
2003-10-30 | 2003-09-30 | 0.39 | 0.22 | -0.17 | 43 | ||
2003-07-29 | 2003-06-30 | 0.47 | 0.52 | 0.05 | 10 | ||
2003-04-29 | 2003-03-31 | 0.38 | 0.39 | 0.01 | 2 | ||
2003-03-04 | 2002-12-31 | 0.57 | 0.6 | 0.03 | 5 | ||
2002-10-29 | 2002-09-30 | 0.46 | 0.47 | 0.01 | 2 | ||
2002-07-25 | 2002-06-30 | 0.38 | 0.39 | 0.01 | 2 | ||
2002-04-25 | 2002-03-31 | 0.3 | 0.32 | 0.02 | 6 | ||
2002-02-21 | 2001-12-31 | 0.43 | 0.46 | 0.03 | 6 | ||
2001-10-29 | 2001-09-30 | 0.36 | 0.37 | 0.01 | 2 | ||
2001-08-01 | 2001-06-30 | 0.25 | 0.3 | 0.05 | 20 | ||
2001-04-26 | 2001-03-31 | 0.18 | 0.2 | 0.02 | 11 | ||
2001-02-28 | 2000-12-31 | 0.26 | 0.28 | 0.02 | 7 | ||
2000-10-27 | 2000-09-30 | 0.25 | 0.27 | 0.02 | 8 | ||
2000-08-02 | 2000-06-30 | 0.16 | 0.17 | 0.01 | 6 | ||
2000-04-28 | 2000-03-31 | 0.1 | 0.1 | 0.0 | 0 | ||
2000-02-24 | 1999-12-31 | 0.19 | 0.2 | 0.01 | 5 | ||
1999-10-28 | 1999-09-30 | 0.17 | 0.18 | 0.01 | 5 | ||
1999-07-28 | 1999-06-30 | 0.12 | 0.12 | 0.0 | 0 | ||
1999-04-29 | 1999-03-31 | 0.09 | 0.09 | 0.0 | 0 | ||
1999-02-26 | 1998-12-31 | 0.13 | 0.14 | 0.01 | 7 | ||
1998-11-27 | 1998-09-30 | 0.12 | 0.12 | 0.0 | 0 | ||
1998-07-28 | 1998-06-30 | 0.09 | 0.09 | 0.0 | 0 | ||
1998-04-29 | 1998-03-31 | 0.07 | 0.07 | 0.0 | 0 | ||
1998-02-25 | 1997-12-31 | 0.08 | 0.13 | 0.05 | 62 | ||
1997-07-24 | 1997-06-30 | 0.07 | 0.07 | 0.0 | 0 | ||
1997-04-28 | 1997-03-31 | 0.06 | 0.06 | 0.0 | 0 | ||
1997-02-27 | 1996-12-31 | 0.06 | 0.07 | 0.01 | 16 | ||
1996-10-29 | 1996-09-30 | 0.06 | 0.06 | 0.0 | 0 | ||
1996-07-17 | 1996-06-30 | 0.04 | 0.06 | 0.02 | 50 | ||
1996-04-17 | 1996-03-31 | 0.03 | 0.05 | 0.02 | 66 |
Bausch Health Corporate Directors
| Sarah Kavanagh | Independent Director | Profile | |
| Richard Schutter | Independent Director | Profile | |
| Amy Wechsler | Independent Director | Profile | |
| Robert Power | Independent Director | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.61) | Earnings Share (0.47) | Revenue Per Share | Quarterly Revenue Growth 0.122 | Return On Assets |
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.